Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Study on age-dependent pre-existing 2009 pandemic influenza virus T and B cell responses from Chinese population.

Lv J, Ren ZY, Zhang YY, Liu YE, Gao J, Yao K, Feng D, Li ZY, Feng X, Liu YX, Jia N.

BMC Infect Dis. 2017 Feb 10;17(1):136. doi: 10.1186/s12879-017-2215-1.

2.

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.

Sridhar S.

Front Immunol. 2016 May 19;7:195. doi: 10.3389/fimmu.2016.00195. eCollection 2016. Review.

3.

Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.

Bolton KJ, McCaw JM, Brown L, Jackson D, Kedzierska K, McVernon J.

PLoS One. 2015 Mar 26;10(3):e0120138. doi: 10.1371/journal.pone.0120138. eCollection 2015.

4.

Influenza, immune system, and pregnancy.

Raj RS, Bonney EA, Phillippe M.

Reprod Sci. 2014 Dec;21(12):1434-51. doi: 10.1177/1933719114537720. Epub 2014 Jun 4. Review.

5.

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.

Herrera MT, Gonzalez Y, Juárez E, Hernández-Sánchez F, Carranza C, Sarabia C, Guzman-Beltran S, Manjarrez ME, Muñoz-Torrico M, Garcia-Garcia L, Sada E, Torres M.

BMC Infect Dis. 2013 Nov 15;13:544. doi: 10.1186/1471-2334-13-544.

6.

Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.

Jegaskanda S, Weinfurter JT, Friedrich TC, Kent SJ.

J Virol. 2013 May;87(10):5512-22. doi: 10.1128/JVI.03030-12. Epub 2013 Mar 6.

7.

Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.

Liu J, Zhang S, Tan S, Yi Y, Wu B, Cao B, Zhu F, Wang C, Wang H, Qi J, Gao GF.

J Virol. 2012 Dec;86(24):13281-94. doi: 10.1128/JVI.01841-12. Epub 2012 Sep 26.

8.

Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation.

Giannandrea M, Yee M, O'Reilly MA, Lawrence BP.

Clin Vaccine Immunol. 2012 Sep;19(9):1432-41. doi: 10.1128/CVI.00265-12. Epub 2012 Jul 11.

9.

Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.

Sridhar S, Begom S, Bermingham A, Ziegler T, Roberts KL, Barclay WS, Openshaw P, Lalvani A.

Eur J Immunol. 2012 Nov;42(11):2913-24. doi: 10.1002/eji.201242504. Epub 2012 Aug 15.

10.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

11.

The human side of influenza.

Oshansky CM, Thomas PG.

J Leukoc Biol. 2012 Jul;92(1):83-96. doi: 10.1189/jlb.1011506. Epub 2012 Feb 23. Review.

12.

Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.

Tselios K, Tsioka R, Sarantopoulos A, Mouloudi E, Boura P.

BMC Infect Dis. 2011 Dec 29;11:358. doi: 10.1186/1471-2334-11-358.

13.

Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.

Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Foisy J, Gubbay J, Rebbapragada A, Winter AL, Achonu C, Ward BJ, Watts TH.

PLoS One. 2011;6(11):e28063. doi: 10.1371/journal.pone.0028063. Epub 2011 Nov 23.

14.

Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates.

Weinfurter JT, Brunner K, Capuano SV 3rd, Li C, Broman KW, Kawaoka Y, Friedrich TC.

PLoS Pathog. 2011 Nov;7(11):e1002381. doi: 10.1371/journal.ppat.1002381. Epub 2011 Nov 10.

15.

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ.

PLoS One. 2011;6(10):e26335. doi: 10.1371/journal.pone.0026335. Epub 2011 Oct 24.

Supplemental Content

Support Center